ABSTRACT GM-CSF produced by autoreactive CD4 positive T helper cells is involved in the pathogenesis of autoimmune diseases, such as Multiple Sclerosis. However, the molecular regulators that establish and maintain the features of GM-CSF positive CD4 T cells are unknown. In order to identify these regulators, we isolated human GM-CSF producing CD4 T cells from human peripheral blood by using a cytokine capture assay. We compared these cells to the corresponding GM-CSF negative fraction, and furthermore, we studied naïve CD4 T cells, memory CD4 T cells and bulk CD4 T cells from the same individuals as additional control cell populations. As a result, we provide a rich resource of integrated chromatin accessibility (ATAC-seq) and transcriptome (RNA-seq) data from these primary human CD4 T cell subsets, and we show that the identified signatures are associated with human autoimmune disease, especially Multiple Sclerosis. By combining information about mRNA expression, DNA accessibility and predicted transcription factor binding, we reconstructed directed gene regulatory networks connecting transcription factors to their targets, which comprise putative key 2 regulators of human GM-CSF positive CD4 T cells as well as memory CD4 T cells. Our results suggest potential therapeutic targets to be investigated in the future in human autoimmune disease.
INTRODUCTION
CD4 positive T helper cells (Th) are crucial players in the immune system which exert their effects mainly by producing cytokines. CD4 T cell subsets are usually classified based on expression of "lineage-defining" transcription factors (TFs) as well as the signature cytokines they secrete 1 .
However, the distinction is not clear-cut, since different signature cytokines can be expressed simultaneously and plasticity between subsets occurs 2, 3 . In view of the "classical" distinction of CD4 T cell subsets, particularly Th1 and Th17 subsets are involved in the establishment of autoimmune diseases such as Multiple Sclerosis (MS) and the corresponding rodent model Experimental Autoimmune Encephalomyelitis (EAE), which are thought to be driven by the T cell-released cytokines Interleukin-17 (IL-17), Interferon-γ (IFN-γ), IL-22 and granulocyte-macrophage colonystimulating factor (GM-CSF). Of these, GM-CSF was determined as the key cytokine in EAE pathogenesis, since only knocking out GM-CSF (but neither IFN-γ, IL-17A nor IL-17F) could completely protect the animals from induced EAE [4] [5] [6] . Furthermore, it has been demonstrated that specifically the GM-CSF produced by autoreactive T cells was necessary for EAE induction, while T cell-produced IFN-γ and IL-17 were dispensable [7] [8] [9] . Importantly, in humans the fraction of GM-CSF positive (and IFN-γ positive) cells within CD4 T cells was elevated in MS patients' cerebrospinal fluid compared to controls, while IL-17A positive cell fractions were not strikingly different in these reports 10, 11 . The fraction of GM-CSF positive and IFN-γ positive cells was also increased in peripheral blood of MS patients in one report 12 , but not in another 10 . Similarly, enhanced fractions of GM-CSF producing CD4 T cells have been observed in synovial fluid of patients with juvenile arthritis along with the well-known enhanced GM-CSF levels in synovial fluid 13, 14 . Of note, targeting GM-CSF in MS or arthritis is subject to several ongoing clinical studies, highlighting the importance of this cytokine in these diseases 14 . Based on this cumulative evidence of the significance of GM-CSF producing CD4 T cells in human autoimmune disease, understanding the factors driving and defining GM-CSF positive T cells would be of utmost importance for targeting them therapeutically.
Murine CD4 T cell populations expressing IL-17A and GM-CSF have been observed and termed "pathogenic Th17" cells because they have the potential to induce EAE [15] [16] [17] . However, only one of these studies showed co-expression of both cytokines on the single cell level 17 . Although a T cell can express GM-CSF simultaneously with other cytokines such as IFN-γ, a "GM-CSF only" producing murine T cell subset was also proposed and associated with enhanced encephalitogenic activity over IL-17 and IFN-γ producing T cells in EAE 9 . The existence of a corresponding separate "GM-CSF-only" human T cell subset has also been proposed 18 , because a substantial subset of human GM-CSF positive CD4 T cells produces GM-CSF in the absence of any other classical Th lineage-defining cytokines, transcription factors or surface markers 10, 19 . Furthermore, GM-CSF producing CD4 T cells are induced by different sets of cytokines compared to other Th cell subsets 18, 20 . In fact, GM-CSF and IL-17A expression by human CD4 T cells has been found to be mutually exclusive on single cell level 10 or at least less frequent than co-expression of IFN-γ and GM-CSF 19, 20 .
Despite the importance of GM-CSF producing T cells, there is no specific marker to distinguish such cells from others to date. Although combinations of presence and absence of non-exclusive surface markers has been useful to delineate "GM-CSF-only" cells 10 , the fraction of GM-CSF producing cells that also produces other cytokines such as IFN-γ is excluded by this approach.
Furthermore, the driving molecules for GM-CSF production remain unclear. Together, these observations suggest that the characterization of human GM-CSF positive CD4 T cells isolated based on their functional profile (GM-CSF production) rather than by distinction of the "classical" Th1 and Due to the limited number of primary, ex vivo isolated GM-CSF positive human cells, we employed a recently described highly sensitive method, assay for transposase-accessible chromatin using sequencing (ATAC-seq) 21 to study DNA accessibility from 50,000 cells per sample. As a control, we used the respective GM-CSF depleted ("GM-CSF negative") fraction derived from the capture assay procedure. Since GM-CSF positive cells may differ from GM-CSF negative CD4 T cells simply by containing largely reduced fractions of naïve cells, we furthermore undertook RNA-seq and ATAC-seq profiling of several control cell populations that is, naïve CD4 T cells and memory CD4 T cells. As an additional control, we studied bulk CD4 T cells without capture assay procedure.
This study hence reveals molecular patterns specific for GM-CSF positive CD4 T cells or shared with memory, naïve or bulk CD4 cells. To our knowledge, this is the first study of global molecular signatures of GM-CSF positive CD4 T cells derived ex vivo without restimulation. Besides serving as a control we furthermore provide a novel resource of ATAC-seq and RNA-seq data of human primary naïve, memory and bulk CD4 T cells from several human healthy donors. A large body of knowledge exists on molecular signatures and regulation of human naïve and memory T cells 22 . This encompasses large consortium efforts to map human memory and naïve CD4 T cell subsets' transcriptomes and epigenomes including chromatin accessibility 23 , albeit these authors did not use the ATAC-seq method. Recently, few reports using ATAC-seq for T cells have been published and the impactful results support the power of the methodology. Nevertheless, a majority of these studies focuses on murine CD8 T cell differentiation and exhaustion [24] [25] [26] [27] [28] while to our knowledge only few studies comprise ATAC-seq on CD4 T cells 21, [29] [30] [31] [32] and none of these studied all the types of CD4 T cell subsets we analyzed here.
Through interpreted, integrative analysis of mRNA expression and DNA accessibility data from primary human CD4 T cell subsets we provide novel gene regulatory networks underlying GM-CSF production as well as the memory phenotype in human CD4 T cells, and we propose novel key TFs regulating these cells. The enrichment of the identified genes for human immune system diseases and specifically MS for GM-CSF positive cells underlines the clinical relevance of our data, which may be exploited in a multitude of basic and applied immunology studies in the future.
MATERIALS AND METHODS

Ethics Statement
Peripheral blood mononuclear cells were freshly isolated from anonymized healthy donor buffy coats purchased from the Karolinska University Hospital (Karolinska Universitetssjukhuset, Huddinge), 
Experimental methods
PBMC and T cell isolation.
Human peripheral blood mononuclear cells (PBMCs) were isolated using Ficoll-Paque gradient centrifugation from buffy coats according to standard procedures. In brief, buffy coats were diluted in PBS, layered on Ficoll-Paque (GE healthcare) and centrifuged at 1200xg for 20 min without break. Subsequently, the PBMC ring was collected. PBMCs were washed with PBS (450xg, 10 min) and monocytes were depleted by plastic adherence in RPMI 1640 medium containing For Donor A, the GM-CSF+ eluate was passed over a second MS column following the LS column procedure, but since a second column did not increase purity but led to loss of cells (data not shown), for all other donors the GM-CSF+ eluate from the first LS column was used for subsequent analyses.
The GM-CSF-fraction from the flow-through was passed over a second column (except for Donor A)
to increase purity of the negative fraction. Yield of GM-CSF+ cells was 1.2±0.6% of CD4 T cells (mean±SD) and purity was controlled by flow cytometry (see below). 
Computational Methods
Preprocessing of sequencing data. BCL base-call files were demultiplexed and converted to FASTQ files using bcl2fastq version 2.17.1.14. For quality control FastQC version 0.11.5 was used.
FASTQ files from the ATAC-seq experiments were trimmed from adapters and low quality bases using scythe version 0.991. and sickle version 1.33. FASTQ files from the ATAC-seq experiments were aligned to the human genome version hg38 using bowtie version 2.3.0 with the '--very-sensitive' option. After alignment, BAM files of ATAC-seq experiments were filtered to eliminate: duplicates (samtools rmdup), alignments with a mapping score below 10, and alignments that are not mapped to chromosome 1-22, chromosome X or Y. ATAC-seq peaks were called using the 'findPeaks' script from the HOMER suite (version 4.9.1) with the '-style factor' option 33 . ATAC-seq peaks were assigned to a gene using the 'annotatePeaks' script from the HOMER suite.
FASTQ files from the RNA-seq experiments were aligned using STAR version 2.5.2b. Indexes for RNA-seq alignment were created using the gencode version 25 annotation file. RNA-seq alignment was run with STAR's built-in adapter trimming option ('--clip3pAdapterSeq AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTA') and its built-in counting option ('--quantMode'). Only genes with more than 1 count per million in at least 3 samples were included in the downstream RNA-seq analysis.
Generation of consensus peak-set. In order to generate a set of comparable features (genomic regions) for read-counting and quantifying differential accessibility from the ATAC-seq data, a set of consensus peaks was generated in two subsequent steps.
(1) Generation of consensus peaks on the technical replicate level: First, the peaks that appeared in at least two technical replicates (out of a total of three, except one donor with a total of two technical replicates) with at least 75% reciprocal overlap were selected. Then these selected regions were partitioned into disjoint non-empty subsets so that each element is contained in precisely one subset. Only the partitions appearing in at least two replicates were retained, and afterwards adjacent regions were merged. A bed file resulting from these steps is herein referred to as a sample. (2) Next, all bed files containing each set of technical replicate level consensus regions were concatenated and the presence of each region was counted within each experimental sample; one occurrence corresponds to one donor (biological replicate) and one cell type (experimental condition). Only the regions appearing in at least four samples were kept (n=5 is the number of biological replicates in the smallest group regarding experimental condition).
Regions having a distance of 42 bases or less between them were subsequently merged (the number 42 corresponds to the sequencing read length in bases). Afterwards, reads were counted using the featureCounts tool 34 with the criterion that at least half of the read had to overlap with a feature to be assigned. 36 .
Comparisons were made between GM-CSF positive CD4
T cells versus GM-CSF negative CD4 T cells, or between memory versus naïve CD4 T cells (see Figure 1A ). The cutoff to call differentially expressed genes (DEGs) or differentially accessible regions (DARs) was FDR<0.05 and >25% fold change (in the direction of either up-or down-regulation).
Footprinting. Footprinting was carried out using the Wellington algorithm 37 , i.e. the wellington_footprints.py script from the pyDNase library version 0.2.5 with the following settings: -fp 6,41,1 -sh 7,36,1 -fdr 0.01 -fdriter 100 -fdrlimit -30 -A. The footprint occupancy score (FOS) for each footprint was calculated using the pyDNase library as described in 38 . For subsequent network reconstruction, we considered only footprints with a FOS smaller than the following threshold:
Network reconstruction. A directed network was reconstructed by combining information from the ATAC-seq and RNA-seq data in two subsequent steps. (1) Identifying source nodes: Peaks were ranked based on their combined measure of significance and direction of differential accessibility [-log 10 (FDR) x sign(log 2 (fold change))]. Peaks containing footprints were scanned for TF binding motifs using the TRANSFAC database 39 . An enrichment score was calculated to identify TFs with binding sites enriched in differentially accessible peaks, using tools similar to gene set enrichment analysis (GSEA) 40 . In detail, random sampling was performed on the ranked list of peaks to assess how probable it is to observe at least the same enrichment by chance (P value) 41 . After multiple test correction, TFs with FDR<0.05 were selected and the normalized enrichment score (NES) was obtained. Only those source nodes (TFs) that were detectably expressed on RNA level (according to a minimal RNA-seq filtering rule) were considered. Of these, most fell into the class of highly expressed genes (HEGs) according to 42 . (2) Identifying target nodes: Target nodes are defined as peaks with an assigned gene. The selection criteria were that (i) the peak contains a footprint with a binding motif of the source node (TF) and (ii) the peak and/or the assigned gene has to be differentially accessible or differentially expressed respectively.
To assign an importance measure to the source nodes in networks generated as above, the PageRank 43 of the network nodes was calculated after inverting the directionality of all edges in the network (only for the purpose of this computation). After this computation, the nodes with high
PageRank values (higher than the 99th percentile of all node values within a given network) were selected from both the GM-CSF and memory network, and afterwards their values were investigated in each of the two networks.
RESULTS AND DISCUSSION
GM-CSF positive CD4 T cells are enriched in MS patients and play a crucial role in EAE; nevertheless the factors driving and markers defining those cells are largely unknown. To better understand the features and regulatory networks of GM-CSF positive CD4 T cells, we therefore studied the transcriptional profiles and chromatin accessibility of these cells. In vitro differentiated GM-CSF producing cells comprise several subsets 20 and are likely to differ from those generated in vivo.
Further, ex vivo re-stimulation with strong artificial stimuli such as PMA and ionomycin -which is usually necessary to reach sufficient signal strength for detection by intracellular cytokine stainingdrastically alters the transcriptome of T cells. Hence, we aimed to isolate GM-CSF producing cells ex vivo in an as much as possible unmanipulated state by GM-CSF secretion assay, "capturing" and isolating those cells that actively secrete GM-CSF (experimental setup, see Figure 1A ), here defined as GM-CSF positive cells. The capture assay was performed starting from highly purified CD4 T cells derived from human peripheral blood (purity 97.3±0.6 %, mean±SEM, Supplementary Figure S1A ). As controls, we used the respective GM-CSF negative fraction from the isolation procedure, as well as the bulk CD4 T cells before any capture assay procedure. The latter should, given the low fraction of GM-CSF positive cells, be very similar to the GM-CSF negative fraction and hence allows for estimation of the effects arising from the capture assay procedure. The purity of GM-CSF positive and GM-CSF negative fractions was assessed by flow cytometry ( Figure 1B ) and the yield of isolated GM- Altogether, we obtained DNA accessibility and transcriptome data from highly purified ex vivo derived human naïve CD4 T cells, memory CD4 T cells, bulk CD4 T cells and well as GM-CSF positive and corresponding GM-CSF negative CD4 T cells. To enable paired analysis within a donor, these cell populations were isolated in parallel within a donor; for 6 donors in total. DNA accessibility and mRNA data were obtained in parallel from the same samples allowing for matched integration of the data.
Unique and shared DNA accessibility and gene expression signatures of GM-CSF positive and memory CD4 T cells.
We studied the above-described five different CD4 T cell populations by RNA-seq and ATAC-seq. To minimize potential batch effects due to technical factors, the library preparations and sequencing runs
were designed in such a way that donors, cell populations, and (for ATAC-seq) technical triplicates were distributed in a balanced fashion. It is also worth noting that only donors of the same gender were studied here (male, age 35.7±8.5 years, mean±SD), which may be important since it was recently shown that gender was the largest source of variation explaining chromatin accessibility in primary human CD4 T cells measured by ATAC-seq 29 . That study further discovered novel elements escaping X chromosome inactivation and affecting immune genes 29 . To assess which factors explained most of the variability between the samples under study here, we performed principle component analysis (PCA). Indeed, for both data types there was a grouping of the samples based on the cell subset, outweighing donor or experimental variation ( Figure 2A , B) and confirming the quality of our samples and data. Notably, for RNA data, the cell populations were generally more distinct from each other than for DNA accessibility data. However, the GM-CSF positive and corresponding GM-CSF negative fraction appeared relatively similar to each other in the PCA performed on RNA data, while PCA results from ATAC-seq data were closer to the expected pattern that is, bulk CD4 T cells appearing "between" GM-CSF positive and GM-CSF negative populations (Figure 2A , B). The difference between RNA-seq and ATAC-seq data with respect to separation of GM-CSF positive and negative cells may indicate that the capture assay procedure imposes distinct changes on the transcriptome, highlighting the importance of using correspondingly treated controls to determine differential expression. In contrast, changes in DNA accessibility appeared more robust towards changes due to the experimental procedure at least within the experimental time frame under study, although the distinction of the other groups was generally less apparent with ATAC-seq data.
Because the first two PCs only explained about 50% of the variation in the data, we also used another dimensionality reduction method to explore the sample-to-sample relationships, namely t-distributed stochastic neighbor embedding (t-SNE) 44 . t-SNE, in contrast to PCA, is a non-linear dimensionality reduction algorithm, and it is suited for capturing local and global relationships at the same time. Next, we studied the DARs and DEGs in more detail. We first focused on the signatures of memory CD4 T cells, which are well studied in the literature 22 and hence enabled to assess the biological quality of our data, besides providing a new NGS data set of human primary memory and naïve CD4
T cells. DARs and DEGs defined in memory cells are shown in Supplementary Figure S2 , along with their molecular patterns in the other cell types under study. We next extracted those memory-specific DARs that were assigned to a gene from a list of genes known to be involved in T cell memory as compiled by Polansky and colleagues 23 . Several of the DARs in memory cells were assigned to such known memory-associated genes, most of those in the promoter region ( Figure 3C ). Furthermore, we assessed a selected subset of memory related genes that were shown to be up-or down-regulated on RNA level in memory T cells 23 . The majority of these genes were DEG in memory cells in our data, notably up-or down-regulated almost exclusively (36 of 37 studied genes; 97%) in the expected direction ( Figure 3D ), validating our data.
The molecular signature of GM-CSF positive CD4 T cells. co-expression of IFN-γ and GM-CSF in some, but not all GM-CSF producing human CD4 single T cells or clonal populations thereof 10, 13, 19, 20, 45 . Also in line with the majority of these studies of human T cells, IL17A and IL17F expression was below detection limit in GM-CSF positive cells (as well as any other cell population under study; data not displayed). It should be noted that CSF2 mRNA, which encodes for GM-CSF, was lowly expressed in all samples (RNA-seq counts close to detection limit), which may be explained by rapid mRNA decay conferred by the adenine and uridine-rich elements (ARE) in the GM-CSF promoter -AREs in fact have been discovered in the CSF2 gene which codes for a particularly unstable transcript [46] [47] [48] . Importantly, considering the instability of CSF2 mRNA and relatively low expression levels, our approach of isolating GM-CSF protein secreting cells is likely to be more suitable to define signatures of ex vivo derived GM-CSF positive cells, as opposed to for example single cell RNA-seq of mixed T cell populations.
Since to our knowledge, there is no other data set available that studied the signatures of purified GM-CSF secreting cells, the RNA expression signatures defined in the GM-CSF positive cells in this study could not be validated externally in an independently published transcriptome data set. Figure 4C ). According to a binomial distribution, the probability of observing this or greater concordance between the two datasets by chance is 7.6%. This needs to be acknowledged considering that those markers that do not concur might be regulated by protein internalization from the surface, such as well-known for CD3 50 that was down-regulated in CyTOF data but barely affected on RNA level. Also, the total abundance of certain proteins may be regulated on post-transcriptional level, as transcript levels cannot always predict protein abundance 51, 52 .
Therefore, we concluded that the expression profile of the GM-CSF positive captured T cells matches well with the profile of independently characterized human GM-CSF positive T cells. supporting the relevance of our data. The data also showed enrichment for several other diseases related to the immune system, infection or metabolism, although it should be noted that some of these contained only few elements (genes) and may thus be less relevant than MS or rheumatoid arthritis, which comprised a large number of genes ( Figure 5A and Supplementary Table S1 ). When performing the same enrichment analysis for the ranked gene list from memory versus naïve CD4 T cells, a large number of diseases were significantly enriched including many diseases involving the immune system, as expected (Supplementary Table S1 ).
GM-CSF
Due to the relevance of GM-CSF positive T cells in MS, we studied in more detail whether DEGs . We studied whether these cells would also display altered expression of the genes we defined as signature genes of GM-CSF positive cells. Indeed, a subset of these genes was down-and another subset was up-regulated in myelin-reactive T cells from MS patients ( Figure 5B ), potentially
identifying genes relevant to the disease pathogenesis. Here, the T cells displayed detectable CSF2
mRNA encoding for GM-CSF, perhaps due to the in vitro stimulation and expansion of these T cells.
Remarkably, only myelin reactive cells from MS patients expressed high levels of CSF2 ( Figure 5B ). , we identified two SNPs mapping to the accessible DNA peaks (considering all consensus peaks) from our study. These SNPs were assigned to the protein-coding genes Regulator
Of G Protein Signaling 1 (RGS1) and Engulfment And Cell Motility 1 (ELMO1) genes respectively ( Figure 5C ). Importantly, the regions containing these SNPs were significantly differentially accessible (FDR<0.05) in GM-CSF positive versus GM-CSF negative cells ( Figure 5C ), suggesting a putative role of these regions in T cell mediated MS pathogenesis.
Relationship of differential gene expression and chromatin accessibility.
Since chromatin accessibility can directly affect gene expression, we next combined the ATAC-seq and RNA-seq data, aiming to identify key TFs that may bind to open chromatin regions and hence affect the expression of their target genes. The methods for calling consensus peaks are not trivial.
Therefore, we first confirmed that the genes assigned to the consensus peaks defined in this study were enriched for several pathways involved in immune regulation including T cell receptor signaling and Th subset differentiation, as well as for immune-related diseases including MS, RA and other autoimmune disease (Supplementary Table S2 ). Furthermore, the distribution of the consensus peaks (open chromatin regions) defined in our data showed an enrichment for being located in CpG islands, promoters, 5' UTRs, exons and protein-coding regions ( Figure 6A ), suggesting that the ATAC-seq data generated here should be well suited to identify TF binding and the expression of corresponding target genes. We first studied the relationship of RNA and chromatin data on a global level: We considered the genes that were both detected on RNA level and also had an ATAC-seq peak assigned to them. We ranked these genes using the -log 10 (FDR)  sign(log(fold change)) function separately for the RNA-seq and ATAC-seq data. Next, we visualized the correlation between these two ranks for each contrast ( Figure 6B ). Considering only the genes significantly changing (FDR<0.05) in the given contrast and assigning them to up-and down-regulated categories, we detected more than random coincidence in the direction of the change between the RNA-seq and ATAC-seq data (using Fisher's exact test with Monte Carlo simulation; Figure 6B ). Increased openness of the chromatin was associated with increased expression of the corresponding gene's RNA for the majority of genes. Less accessible chromatin also coincided with low expression of the corresponding gene in many cases, although a substantial fraction of lowly accessible regions also displayed high expression of the corresponding gene ( Figure 6C ).
Identification of key TFs linked to the signatures of GM-CSF positive and memory CD4 T cells.
To identify potential TFs that may establish the gene signatures of GM-CSF positive (versus GM-CSF negative) and memory (versus naïve) CD4 T cells, we scanned the consensus peaks for footprints and subsequently we scanned the identified footprints for TF binding motifs. For motif scanning we used the TRANSFAC database 39 that contains experimentally validated binding sites, consensus binding sequences (positional weight matrices) and regulated genes of eukaryotic TFs. Confirming the methodology used to identify footprints, they were enriched in differentially accessible regions as expected for the corresponding cell type comparisons (Supplementary Figure S3) . Next, we defined the TFs whose binding sites were most enriched in peaks of GM-CSF positive or memory cells respectively (ranked based on differentially accessibility), and identified about 20 TFs each that passed the significance threshold (FDR<0.05) for enrichment ( Figure 7A ). These lists contained several TFs with a well-known role in T cells, such as SATB1, YY1, ETS-and EGR-family TFs, among other factors with a less defined role. Notably there was little overlap between the key TFs in GM-CSF positive and memory cells, suggesting that our strategy may have identified key factors to specifically define the GM-CSF positive T cell phenotype. The majority of these TFs were highly expressed on RNA level ( Figure 7B ), falling within the class of highly expressed genes (HEGs) that were suggested to be more functional than lowly expressed genes 42 . Interestingly however, most of these TFs were not differentially expressed themselves in the cell population comparisons under study ( Figure 7C ), suggesting that they may be regulated on post-transcriptional levels such as protein phosphorylation and intracellular localization which is well-known for many TFs. Hence, with a strategy exploring solely the transcriptome (or even proteome) without integrating ATAC-seq data, several key TFs would likely be missed, while our integrative strategy combining RNA-seq and ATACseq data successfully identified such TFs from limited amounts of primary human T cells.
Integration of RNA-seq and ATAC-seq data identifies gene regulatory networks of GM-CSF positive and memory CD4 T cells.
Having identified key TFs in GM-CSF positive and memory CD4 T cells, we were interested whether these factors regulated certain groups of target genes and whether several TFs may act together in a concerted fashion. Some TFs regulated a large number of target genes, and clusters of TFs were grouping together ( Figure 8A, B) . Exploring the co-binding between TFs in more detail showed that certain groups of TFs bound together to the same targets ( Figure 8C, D) . These included the TCF3:LEF1 pair that was always co-binding the same regions, as evident from the Memory/Naïve
CD4 T cell contrast (Figure 8B, D). TCF/LEF family proteins act downstream of the Wnt pathway and
it is well-known that they often display overlapping expression patterns and functional redundancy 57 .
In accordance with our data on human memory and naïve CD4 T cells, binding motifs for TCF family members were recently also determined to be depleted in murine memory CD8 T cells as well as human memory CD4 T cells using ATAC-seq 28, 32 .
Finally, by connecting the TFs to the genes assigned to their target regions, we generated a directed gene regulatory network representing GM-CSF positive (versus negative) and memory (versus naïve) CD4 T cells respectively ( Figure 9 ). The source nodes were represented by the key TFs as selected above (key TFs from Figure 7A , B) and target nodes were selected when the region was either differentially accessible and/or the mRNA of the assigned gene was differentially expressed in the respective cell population comparisons. Both the GM-CSF as well as the memory comparisons led to similarly sized networks however, only some of the target and source nodes were shared between both networks ( Figure 9A, B) .
To quantify the importance of the source nodes in each individual network as well as in the comparison of both networks, we calculated scores based on the PageRank algorithm 43 . To do such a calculation on a network where the outgoing edges from a TF reflect its importance, rather than the incoming edges like in the original application of the algorithm, the edges in our networks were On the other hand, capturing multiple cytokine-producing Th subsets in parallel from the same donor without artificially raising their fraction by PMA and ionomycin was not feasible in our study due to the limited cell numbers. Together, our data on naïve, memory, and GM-CSF positive CD4 T cells (and corresponding controls) can be exploited for a multitude of future studies for basic and translational immunology concerning autoimmune diseases and beyond. Further, our data can be a test-bed for bioinformatics method development for the integration of RNA-seq and ATAC-seq data from the same samples, which may help understanding basic principles of gene regulation in primary eukaryotic cells.
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